Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA

References

• Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953;249:553–6.
   PubMed Web of Science ®Google Scholar
• Duthie JJ, Brown PE, Truelove LH, Baragar FD, Lawrie AJ. Course and prognosis in rheumatoid arthritis. A further report. Ann Rheum Dis 1964;23:193–204.
   PubMed Web of Science ®Google Scholar
• Uddin J, Kraus AS, Kelly HG. Survivorship and death in rheumatoid arthritis. Arthritis Rheum 1970;13:125–30.
   PubMed Web of Science ®Google Scholar
• Allebeck P. Increased mortality in rheumatoid arthritis. Scand J Rheumatol 1982;11:81–6.
   PubMed Web of Science ®Google Scholar
• Mutru O, Laakso M, Isomaki H, Koota K. Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J 1985;290:1797–9.
   PubMed Web of Science ®Google Scholar
• Pincus T, Brooks RH, Callahan LF. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med 1994;120:26–34.
   PubMed Web of Science ®Google Scholar
• Symmons DP, Jones MA, Scott DL, Prior P. Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol 1998;25:1072–7.
   PubMed Web of Science ®Google Scholar
• Bjornadal L, Baecklund E, Yin L, Granath F, Klareskog L, Ekbom A. Decreasing mortality in patients with rheumatoid arthritis: results from a large population-based cohort in Sweden, 1964–95. J Rheumatol 2002;29:906–12.
   PubMed Web of Science ®Google Scholar
• Book C, Saxne T, Jacobsson LT. Prediction of mortality in rheumatoid arthritis based on disease activity markers. J Rheumatol 2005;32:430–4.
   PubMedGoogle Scholar
• Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S, Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology 2007;46:350–7.
   PubMed Web of Science ®Google Scholar
• Kroot EJ, van Leeuwen MA, van Rijswijk MH, Prevoo ML, Van ‘t Hof MA, van De Putte LB, No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann Rheum Dis 2000;59:954–8.
   PubMed Web of Science ®Google Scholar
• Prior P, Symmons DP, Scott DL, Brown R, Hawkins CF. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984;23:92–9.
   PubMedGoogle Scholar
• Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002;359:1173–7.
   PubMed Web of Science ®Google Scholar
• Jacobsson LT, Turesson C, Nilsson JA, Petersson IF, Lindqvist E, Saxne T, Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Ann Rheum Dis 2007;66:670–5.
   PubMed Web of Science ®Google Scholar
• Carmona L, Descalzo MA, Perez-Pampin E, Ruiz-Montesinos D, Erra A, Cobo T, All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists. Ann Rheum Dis 2007;66:880–5.
   PubMed Web of Science ®Google Scholar
• Gabriel SE, Crowson CS, O'Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades?. J Rheumatol 1999;26:2529–33.
   PubMed Web of Science ®Google Scholar
• Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM3rd, Therneau TM, The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007;56:3583–7.
   PubMed Web of Science ®Google Scholar
• Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis:a population-based study. Arthritis Rheum 2005;52:722–32.
   PubMed Web of Science ®Google Scholar
• Wallberg-Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997;24:445–51.
   PubMed Web of Science ®Google Scholar
• Goodson N, Marks J, Lunt M, Symmons D. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis 2005;64:1595–601.
   PubMed Web of Science ®Google Scholar
• Meune C, Touze E, Trinquart L, Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology 2009;48:1309–13.
   PubMed Web of Science ®Google Scholar
• Okuda Y, Takasugi K, Imai A, Oyama T, Oyama H, Kawamura S. Clinical study of rheumatoid interstitial lung disease evaluated by high resolution CT. Ryumahci 1993;33:12–19.
   Google Scholar
• Ohsone Y, Okano Y, Kameda H, Fujii T, Hama N, Hirakata M, Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis. J Rheumatol 1997;24:2299–303.
   PubMedGoogle Scholar
• Harigai M, Koike R, Miyasaka N. Group PPuA-TNFTPS. Pneumocystis pneumonia associated with infliximab in Japan. N Engl J Med 2007;357:1874–76.
   PubMed Web of Science ®Google Scholar
• Yoshizawa H, Kudo H, Iwano K, Yamada A, Aikawa T, Miyamoto Y, Causes of death in patients with rheumatoid arthritis: analysis of 117 cases for 13 years. Ryumachi 1990;30:255–63.
   PubMedGoogle Scholar
• Toyoshima H, Kusaba T, Yamaguchi M. Cause of death in autopsied RA patients. Ryumachi 1993;33:209–14.
   PubMedGoogle Scholar
• Suzuki A, Ohosone Y, Obana M, Mita S, Matsuoka Y, Irimajiri S. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 1994;21:33–6.
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Tatsuki Y, Nagami Y, Ishiguro N, Tanaka Y, Yamanaka H, Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis 2008;67:189–94.
   PubMed Web of Science ®Google Scholar
• Hakoda M, Oiwa H, Kasagi F, Masunari N, Yamada M, Suzuki G, Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study. Ann Rheum Dis 2005;64:1451–5.
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Inoue E, Tanaka E, Nakajima A, Taniguchi A, Terai C, Influence of methotrexate dose on its efficacy and safety in rheumatoid arthritis patients: evidence based on the variety of prescribing approaches among practicing Japanese rheumatologists in a single institute-based large observational cohort (IORRA). Mod Rheumatol 2007;17:98–105.
   PubMedGoogle Scholar
• Nakajima A, Kamitsuji S, Saito A, Tanaka E, Nishimura K, Horikawa N, Disability and patient's appraisal of general health contribute to depressed mood in rheumatoid arthritis in a large clinical study in Japan. Mod Rheumatol 2006;16:151–7.
   PubMedGoogle Scholar
• Yamada T, Nakajima A, Inoue E, Tanaka E, Hara M, Tomatsu T, Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan. Ann Rheum Dis 2006;65:1661–3.
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Inoue E, Singh G, Tanaka E, Nakajima A, Taniguchi A, Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan. Mod Rheumatol 2007;17:283–9.
   PubMedGoogle Scholar
• Tanaka E, Kamitsuji S, Inoue E, Yamada T, Nakajima A, Takeuchi E, Nonsteroidal anti-inflammatory drug use dose not affect short-term endoscopic and histologic outcomes after Helicobacter pylori eradication in patients with rheumatoid arthritis. Mod Rheumatol 2007;17:228–34.
   PubMedGoogle Scholar
• Furuya T, Kotake S, Inoue E, Nanke Y, Yago T, Kobashigawa T, Risk factors associated with incident clinical vertebral and nonvertebral fractures in Japanese women with rheumatoid arthritis: a prospective 54-month observational study. J Rheumatol 2007;34:303–10.
   PubMed Web of Science ®Google Scholar
• Momohara S, Inoue E, Ikari K, Kawamura K, Tsukahara S, Mochizuki T, Risk factors for total knee arthroplasty in rheumatoid arthritis. Mod Rheumatol 2007;17:476–80.
   PubMedGoogle Scholar
• Matsuda Y, Singh G, Yamanaka H, Tanaka E, Urano W, Taniguchi A, Validation of a Japanese version of the Stanford health assessment questionnaire in 3,763 patients with rheumatoid arthritis. Arthritis Rheum 2003;49:784–8.
   PubMed Web of Science ®Google Scholar
• Tsuji F, Seki I, Aono H, Odani N, Mizutani K, Okamoto M, Bucillamine mechanism inhibiting IL-1beta-induced VEGF production from fibroblast-like synoviocytes. Int Immunopharmacol 2007;7:1569–76.
   PubMed Web of Science ®Google Scholar
• Iwatani M, Inoue E, Nakamura T, Nakajima A, Hara M, Tomatsu T, Efficacy profile of bucillamine in rheumatoid arthritis patients in a large observational cohort study, IORRA. Mod Rheumatol 2006;16:376–80.
   PubMedGoogle Scholar
• Kauppi M, Sokka T, Hannonen P. Survey nonresponse is associated with increased mortality in patients with rheumatoid arthritis and in a community population. J Rheumatol 2005;32:807–10.
   PubMed Web of Science ®Google Scholar
• Sokka T. National databases and rheumatology research I: Longitudinal databases in Scandinavia. Rheum Dis Clin North Am 2004;30:851–67.
   PubMedGoogle Scholar
• Barchielli A, Baizi D. Nine-year follow-up of a survey on smoking habits in Florence (Italy): higher mortality among non-responders. Int J Epidemiol 2002;31:1038–42.
   PubMed Web of Science ®Google Scholar
• Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S, Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 2006;65:1608–12.
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 2006;83:456S–60S.
   PubMed Web of Science ®Google Scholar
• Sidiropoulos PI, Siakka P, Pagonidis K, Raptopoulou A, Kritikos H, Tsetis D, Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients. Scand J Rheumatol 2009;38:6–10.
   PubMed Web of Science ®Google Scholar
• Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402–11.
   PubMed Web of Science ®Google Scholar
• Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, Uesato M, A novel single-nucleotide polymorphism at the 5′-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis. Arthritis Rheum 2001;44:1266–72.
   PubMed Web of Science ®Google Scholar
• Calguneri M, Ureten K, Akif Ozturk M, Onat AM, Ertenli I, Kiraz S, Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol 2006;24:305–8.
   PubMed Web of Science ®Google Scholar